Viewing Study NCT01426334


Ignite Creation Date: 2025-12-25 @ 2:25 AM
Ignite Modification Date: 2026-03-11 @ 10:28 PM
Study NCT ID: NCT01426334
Status: TERMINATED
Last Update Posted: 2014-04-02
First Post: 2011-08-30
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Dasatinib and Cyclosporine in Treating Patients With Chronic Myelogenous Leukemia Refractory or Intolerant to Imatinib Mesylate
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module